Basics Genelux Corporation Common Stock IPO Date: January 26, 2023 Sector: Healthcare Industry: Biotech Market Cap: $116.72M Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 4.85% Avg Daily Range (30 D): $0.14 | 3.41% Avg Daily Range (90 D): $0.21 | 4.01% Institutional Daily Volume Avg Daily Volume: .13M Avg Daily Volume (30 D): .22M Avg Daily Volume (90 D): .21M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 116 Avg Trade Size (Sh.) (90 D): 109 Institutional Trades Total Inst.Trades: 30 Avg Inst. Trade: $3.3M Avg Inst. Trade (30 D): $.71M Avg Inst. Trade (90 D): $.86M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.12M Avg Closing Trade (30 D): $.71M Avg Closing Trade (90 D): $.71M Avg Closing Volume: 400.2K     News Jan 12, 2026 @ 9:00 PM Genelux Corporation Announces Upcoming Virtual Fir... Source: Not Specified Jan 2, 2026 @ 1:00 PM Genelux Corporation Announces Appointment of Jason... Source: Na Sep 3, 2024 @ 8:01 PM Genelux Corporation to Present at the H.C. Wainwri... Source: N/A Jul 30, 2024 @ 11:00 AM Genelux Corporation to Participate in Fireside Cha... Source: N/A May 31, 2024 @ 4:01 PM Unveiling 4 Analyst Insights On Genelux Source: Benzinga Insights Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.88 $-.21 $-.2 Diluted EPS $-.88 $-.21 $-.2 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -31.87M $ -7.95M $ -7.46M Operating Income / Loss $ -33.55M $ -8.19M $ -7.79M Cost of Revenue $ $ $ Net Cash Flow $ -1.41M $ -1.85M $ -9.66M PE Ratio